Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5464)
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
16
Price
$234.00
Total Value
$3.74K
Shares Held After
139,486
% of Holdings
0.0%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
600
Price
$233.24
Total Value
$139.94K
Shares Held After
139,502
% of Holdings
0.4%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
850
Price
$232.33
Total Value
$197.48K
Shares Held After
140,102
% of Holdings
0.6%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
576
Price
$230.84
Total Value
$132.96K
Shares Held After
140,952
% of Holdings
0.4%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
878
Price
$229.96
Total Value
$201.90K
Shares Held After
141,528
% of Holdings
0.6%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
80
Price
$228.50
Total Value
$18.28K
Shares Held After
142,406
% of Holdings
0.1%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
100
Price
$3.05
Total Value
$305.00
Shares Held After
231,138
% of Holdings
0.0%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
100
Price
$3.07
Total Value
$307.00
Shares Held After
231,238
% of Holdings
0.0%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
10
Price
$3.05
Total Value
$30.50
Shares Held After
231,338
% of Holdings
0.0%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
90
Price
$3.05
Total Value
$274.50
Shares Held After
231,348
% of Holdings
0.0%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
100
Price
$3.07
Total Value
$307.00
Shares Held After
231,438
% of Holdings
0.0%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
50
Price
$3.05
Total Value
$152.50
Shares Held After
231,538
% of Holdings
0.0%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
100
Price
$3.06
Total Value
$306.00
Shares Held After
231,588
% of Holdings
0.0%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
50
Price
$3.05
Total Value
$152.50
Shares Held After
231,688
% of Holdings
0.0%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
82
Price
$3.05
Total Value
$250.10
Shares Held After
231,738
% of Holdings
0.0%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
98
Price
$3.05
Total Value
$298.90
Shares Held After
231,820
% of Holdings
0.0%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
417
Price
$3.05
Total Value
$1.27K
Shares Held After
231,918
% of Holdings
0.2%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
50
Price
$3.05
Total Value
$152.50
Shares Held After
232,335
% of Holdings
0.0%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
2
Price
$3.05
Total Value
$6.10
Shares Held After
232,385
% of Holdings
0.0%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
183
Price
$3.05
Total Value
$558.15
Shares Held After
232,387
% of Holdings
0.1%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
100
Price
$3.05
Total Value
$305.00
Shares Held After
232,570
% of Holdings
0.0%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
100
Price
$3.05
Total Value
$305.00
Shares Held After
232,670
% of Holdings
0.0%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
50
Price
$3.05
Total Value
$152.50
Shares Held After
232,770
% of Holdings
0.0%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
100
Price
$3.05
Total Value
$305.00
Shares Held After
232,820
% of Holdings
0.0%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
50
Price
$3.05
Total Value
$152.50
Shares Held After
232,920
% of Holdings
0.0%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
18
Price
$3.05
Total Value
$54.90
Shares Held After
232,970
% of Holdings
0.0%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
50
Price
$3.05
Total Value
$152.50
Shares Held After
232,988
% of Holdings
0.0%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
50
Price
$3.05
Total Value
$152.50
Shares Held After
233,038
% of Holdings
0.0%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
50
Price
$3.05
Total Value
$152.50
Shares Held After
233,088
% of Holdings
0.0%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
500
Price
$3.05
Total Value
$1.52K
Shares Held After
233,138
% of Holdings
0.2%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
200
Price
$3.06
Total Value
$612.00
Shares Held After
233,638
% of Holdings
0.1%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
100
Price
$3.04
Total Value
$304.00
Shares Held After
233,838
% of Holdings
0.0%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
4
Price
$3.05
Total Value
$12.20
Shares Held After
233,938
% of Holdings
0.0%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
4
Price
$3.05
Total Value
$12.20
Shares Held After
233,942
% of Holdings
0.0%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
10
Price
$3.05
Total Value
$30.50
Shares Held After
233,946
% of Holdings
0.0%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
100
Price
$3.05
Total Value
$305.00
Shares Held After
233,956
% of Holdings
0.0%
Zentalis Pharmaceuticals, Inc. (ZNTL)
Vultaggio Vincent — PAO and PFO
Shares
2,540
Price
$2.55
Total Value
$6.48K
Shares Held After
187,286
% of Holdings
1.3%
OCULAR THERAPEUTIX, INC (OCUL)
Notman Donald — Chief Operating Officer
Shares
5,455
Price
$9.14
Total Value
$49.86K
Shares Held After
383,837
% of Holdings
1.4%
Arcutis Biotherapeutics, Inc. (ARQT)
Matsuda Masaru — Reporting Person's title: SVP General Counsel and Corporate Secretary
Shares
4,714
Price
$25.63
Total Value
$120.82K
Shares Held After
110,003
% of Holdings
4.1%
Arcutis Biotherapeutics, Inc. (ARQT)
Matsuda Masaru — Reporting Person's title: SVP General Counsel and Corporate Secretary
Shares
19,379
Price
$25.24
Total Value
$489.13K
Shares Held After
114,717
% of Holdings
14.5%
Arcutis Biotherapeutics, Inc. (ARQT)
Matsuda Masaru — Reporting Person's title: SVP General Counsel and Corporate Secretary
Shares
8,562
Price
$24.97
Total Value
$213.79K
Shares Held After
134,096
% of Holdings
6.0%
Arcutis Biotherapeutics, Inc. (ARQT)
Matsuda Masaru — Reporting Person's title: SVP General Counsel and Corporate Secretary
Shares
7,983
Price
$25.50
Total Value
$203.55K
Shares Held After
142,658
% of Holdings
5.3%
Sionna Therapeutics, Inc. (SION)
Thompson Peter A. — Director
Shares
1,890
Price
$44.57
Total Value
$84.24K
Shares Held After
3,559,765
% of Holdings
0.1%
Adaptive Biotechnologies Corp (ADPT)
ROBINS HARLAN S — Chief Scientific Officer
Shares
34,668
Price
$18.60
Total Value
$644.82K
Shares Held After
1,187,644
% of Holdings
2.8%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
100
Price
$66.89
Total Value
$6.69K
Shares Held After
183,371
% of Holdings
0.1%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
1,108
Price
$66.15
Total Value
$73.29K
Shares Held After
183,471
% of Holdings
0.6%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
792
Price
$65.21
Total Value
$51.65K
Shares Held After
184,579
% of Holdings
0.4%
Arcutis Biotherapeutics, Inc. (ARQT)
Vairavan Latha — SVP Chief Financial Officer
Shares
1,320
Price
$25.50
Total Value
$33.66K
Shares Held After
63,607
% of Holdings
2.0%
Arcutis Biotherapeutics, Inc. (ARQT)
Edwards Larry Todd — Reporting Person's title: EVP Chief Commercial Officer
Shares
2,052
Price
$25.50
Total Value
$52.32K
Shares Held After
148,865
% of Holdings
1.4%
Arcutis Biotherapeutics, Inc. (ARQT)
Welgus Howard G. — Director
Shares
10,000
Price
$25.05
Total Value
$250.48K
Shares Held After
59,744
% of Holdings
14.3%
Showing 3251–3300 of 5464 transactions (page 66 of 110)